tbuckley/cabot-search huggingface dataset:
EP07.05-02 NEOEAST: A Phase II Study of Ensartinib as Neoadjuvant Therapy for Stage II-IIIB ALK-rearranged Non-small Cell Lung Cancer
Authors: F.-L. Lu, C. Lv, M.-L. Zhuo, X. Yang, S. Yan, J.-F. Chen, N. Wu
Journal: Journal of Thoracic Oncology (2023)
EP01.01-25 Occupational Exposure and Lung Cancer Risk in Women: A Pooling Study
Authors: C. Candal-Pedreira, E. Torres, J. Rey-Brandariz, C. Guerra-Tort, L. Varela-Lema, M. Pérez-Ríos, A. Ruano-Ravina
Journal: Journal of Thoracic Oncology (2023)
P1.17-01 Lung Cancer Screening in Low- and Middle-income Countries - Report on Status, Challenges and Perspectives from WCLC2022 and LALCA2023
Authors: M. Cavic, L. Viola, A. Kerpel-Fronius, L. Ventura, L. Jiang, R. Sales dos Santos, D. Yang, C. Koegelenberg, J. Zulueta, C. Henschke, E.A. Kazerooni, M. Tammemägi, J. Field, H. Balata, D. Yankelevitz, A. Mohan, S. Lam, R.M. Huber
Journal: Journal of Thoracic Oncology (2023)
P1.14-03 How Do Patients with Screening-Detected Pulmonary Nodules, Experience and React to Being under Surveillance?
Authors: E. Katsampouris, A. Creamer, R. Prendecki, E. Clark, J. Dickson, R. Lee, S. Janes, S. Duffy, S. Quaife
Journal: Journal of Thoracic Oncology (2023)
EP07.04-29 Hyperspectral Multiplex Immunohistochemistry and Recurrence in Resected Early Stage Non-small Cell Lung Cancer
Authors: A.L. McGuire, M. Guillaud, K. Noureddine, S. Martin, J.C. English, R. Xiang, P. Arora, C. MacAulay
Journal: Journal of Thoracic Oncology (2023)
P1.22-17 Addressing Lung Cancer Biomarker Testing Through the ECHO Model - Results from a 3-State Pilot in the United States
Authors: L.S. Rosenthal, K.M. Hofmann, K.H. Goss, L. Thompson, M. Wessel, E. Dickson-Gavney, R.A. Smith
Journal: Journal of Thoracic Oncology (2023)
P2.16-04 Assessment of the Efficacy and Safety of Durvalumab Associated with Platinum-Etoposide in Previously Untreated ES-SCLC in Brazil
Authors: D. Lopes, M. Zukin, A. Calabrich, V. Cordeiro de Lima, M. Corassa, G. Gössling, C. L, R. Gomes de Jesus
Journal: Journal of Thoracic Oncology (2023)
MA13.03 BBT-176, a 4th Generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: Updated Report from a Phase 1 Study
Authors: S.M. Lim, J.S. Ahn, D.-W. Kim, Y.J. Kim, M. Nagasaka, Y.-H. Lee, E.Y. Park, H.E. Kim, J. Cho, S. Jung, S.-Y. Lee
Journal: Journal of Thoracic Oncology (2023)
P2.05-02 MAPK1/MAPK3 Mutations Enhance Immunotherapy Efficacy in Lung Squamous Cell Carcinoma (LSCC): Results of the SQUINT Trial
Authors: F. Cappuzzo, F. Fusco, L. Bonanno, L. Landi, K. Andrikou, A. Dal Maso, G. Minuti, M. Papi, G. Metro, W.K. Lye, P. Ariyaratne, Y. Yu, W.M. Lau, X. Wang, J. Lucke, A. Görtz, I. Attili, F. Piantedosi, S. Pilotto, S. Gori, G. Rossi, S. Buglioni, D. Giannarelli, A. Delmonte
Journal: Journal of Thoracic Oncology (2023)
P2.10-02 Liquid Biopsy-based Umbrella Trial for Advanced NSCLC: Results of Phase 2 Plasma ALK-positive Cohort (A-Liquid)
Authors: Y. Nakatani, K. Nosaki, A. Sugimoto, H. Udagawa, T. Kato, J. Sakakibara-Konishi, H. Horinouchi, K. Ohashi, R. Toyozawa, T. Sakamoto, M. Morise, T. Ikeno, S. Nomura, H. Izumi, S. Matsumoto, K. Goto
Journal: Journal of Thoracic Oncology (2023)
P2.08-02 STAR-121: Phase 3 Study of DOM and ZIM plus Chemo vs Pembro plus Chemo in 1L mNSCLC with No Actionable Gene Alterations
Authors: D. Rodriguez-Abreu, J. Bosch-Barrera, J.E. Gray, M.J. Ahn, M. Johnson, X. Yu, S. Mohammad, X. Chen, P. Phuong, J. Kim, M. Reck
Journal: Journal of Thoracic Oncology (2023)
EP06.05-06 Distant Metastasis Pattern and Baseline Clinicopathological Features from a Real-World KRAS G12C Mutant Cohort of Advanced NSCLC Patients
Authors: L. Mollica, S. Intagliata, L. Bonomi, L. Ghilardi, D. Morotti, G. Ghirardi, E. Antelmi, A. Gianatti, G. Carioli, R. Muglia, P. Marra, F. Raimondi, G. Ciaravino, F. Di Marco, S. Sironi, C.A. Tondini, A.C. Bettini
Journal: Journal of Thoracic Oncology (2023)
P1.01-06 A Phase IB Trial Of Nivolumab For Immunoprevention Of Bronchial Dysplasia Progression In High-risk Current And Former Smokers
Authors: H. Yu, D.T. Merrick, H. Li, M. Ghosh, M. New, M. Baloneque-Siqueira, B. Kubala, J. Hu, N. Pakosz, H. Schumann, A. Van Bokhoven, Y.E. Miller, R.L. Keith
Journal: Journal of Thoracic Oncology (2023)
EP12.03-02 Previously Treated Advanced-Disease NSCLC KRAS G12C From a Canadian Multi-Institutional Real-World Evidence Database (CARMA)
Authors: L.J. Zhan, S. Barghout, S. Raptis, F. Al-Agha, A. Popovacki, N. Esfahanian, G. Kasymjanova, F. Proulx-Rocray, S. Chan, M. Richardson, M.C. Brown, D. Patel, M.L. Dean, V. Navani, E. Moore, L. Carvery, E. Yan, J. Cleary-Gosine, A.J. Gibson, L. Hubley, K. Balaratnam, T. Ngo, A. Gill, M. Black, A. Sacher, P.A. Bradbury, F. Shepherd, N. Leighl, P. Cheema, S. Kuruvilla, J. Agulnik, S. Banerji, R. Juergens, N. Blais, W. Cheung, P. Wheatley-Price, G. Liu, S. Snow
Journal: Journal of Thoracic Oncology (2023)
EP04.04-04 Relevance of AI (qCT) In Automated Progression Monitoring of Pulmonary Nodules in Follow-up Lung CT Scans
Authors: R. Agrawal, S. Kumar, V. Challa, P. Vanapalli, S. Mandal, M. Shukla, A. Modi, P. Putha, P. Warier
Journal: Journal of Thoracic Oncology (2023)
P1.26-10 Is Mediastinal Lymph Node Dissection Necessary in Segmentectomy for Peripheral Stage IA (≤2 CM) Non-small-Cell Lung Cancer?
Authors: H. Adachi, H. Ito, T. Isaka, K. Murakami, J. Miura, N. Kikunishi, N. Shigeta, Y. Kudo, Y. Miyata, M. Okada, N. Ikeda
Journal: Journal of Thoracic Oncology (2023)
P2.21-07 A Novel Proteomic Technique Uncovers New Diagnostic Biomarkers for Malignant Pleural Mesothelioma
Authors: K. Lamote, E. Schillebeeckx, E. Fernandez, A. Staes, J.P. van Meerbeeck, K. Gevaert
Journal: Journal of Thoracic Oncology (2023)
MA17.10 miRNA Signatures In Mesothelioma and their Associations with Outcomes with Immune Checkpoint Inhibitors
Authors: F. Kosari, M. Disselhorst, T. Peikert, S.H. Johnson, S.J. Murphy, G. Karagouga, J.L. Schaefer Klein, G. Vasmatzis, P. Baas, A.S. Mansfield
Journal: Journal of Thoracic Oncology (2023)
P1.25-13 Enhanced Assessment Of Recurrence Risk Of Stage I NSCLC By Combined Adenocarcinoma Grading System And Serum Proteomic Testing
Authors: H. Pass, J.A. Borgia, H. Roder, J. Roder, L. Net, L. Maguire, C. Goparaju, A. Moreira
Journal: Journal of Thoracic Oncology (2023)
EP07.02-15 Longitudinal ctDNA Testing in Resected, Early Stage Non-small Cell Lung Cancers
Authors: J. Feng, T. Waddell, K. Yasufuku, D. Kelly, N. Meti, A. Pierre, S. Keshavjee, J. Yeung, M. Cypel, L. Donahoe, E. Wakeam, M. de Perrot, J. Law, A. Salvarrey, L.W. Le, J. Lister, M. Cabanero, M.S. Tsao, C. Pipinikas, K. Howarth, N.B. Leighl
Journal: Journal of Thoracic Oncology (2023)
EP08.02-05 Neoadjuvant Immunochemotherapy Combined with Probiotic Supplements in Stage IIB-IIIB NSCLC: A Real-World Prospective Study
Authors: J. Jiang, J. Mei, Z. Yuan, J. Yin, Z. Liu, Y. Gao, M. Li
Journal: Journal of Thoracic Oncology (2023)
EP08.02-15 Moderately Hypofractionated PET/CT-Based Thoracic Radiotherapy in Elderly and Multimorbid Patients with Stage II/III NSCLC
Authors: H. Kravutske, J. Lehmann, J.E. Guggenberger, S. Mansoorian, J. Taugner, L. Käsmann, C. Belka, F. Manapov, C. Eze
Journal: Journal of Thoracic Oncology (2023)
P2.12-02 Beware: Tyrosine Kinase Inhibitors for Lung Cancers that Inhibit MATE-1 can Lead to "False” Decreases in Renal Function
Authors: M. Chen, G. Harada, D. Liu, R. Dematteo, C. Falcon, C. Wilhelm, M.G. Kris, A.E. Drilon
Journal: Journal of Thoracic Oncology (2023)
P2.09-22 Efﬁcacy of Aumolertinib in EGFR T790M-negative or -unknown NSCLC with Brain Metastases Following Resistance to Prior EGFR-TKIs
Authors: C.B. Han, Z.X. Dai, B. Jin, W. Cui, L. Man, H.J. Zhang
Journal: Journal of Thoracic Oncology (2023)
MA13.10 Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer: Primary Results of DESTINY-Lung02
Authors: P. Janne, Y. Goto, T. Kubo, K. Ninomiya, S.-W. Kim, D. Planchard, M.-J. Ahn, E.F. Smit, A.J. de Langen, M. Pérol, E. Pons-Tostivint, S. Novello, H. Hayashi, J. Shimizu, D.-W. Kim, K. Pereira, F.-C. Cheng, A. Taguchi, Y. Cheng, K. Goto
Journal: Journal of Thoracic Oncology (2023)
EP08.02-07 FDG PET Scan Based Response Assesment in Non-Small Cell Lung Cancer Treated With Chemoradiotherapy And Neoadjuvant Chemotherapy
Authors: A. Ahmad, S.K.D. Majumdar, D.K. Parida, S.K. Barik, D.K. Das, D.Y. Bagul, L. Shaikh, N. Amin
Journal: Journal of Thoracic Oncology (2023)
MA06.04 KRYSTAL-1: Two-Year Follow-Up of Adagrasib (MRTX849) Monotherapy in Patients with Advanced/Metastatic KRASG12C-Mutated NSCLC
Authors: S. Gadgeel, P.A. Jänne, A.I. Spira, S.-H.I. Ou, R.S. Heist, J.M. Pacheco, M.L. Johnson, J.K. Sabari, K. Leventakos, J.A. Mason, K. Velastegui, X. Yan, R. Chao, G.J. Riely
Journal: Journal of Thoracic Oncology (2023)
P1.02-03 Identifying Biomarkers of Response to Ensartinib, Lorlatinib, and Alectinib in an ALK+ Non-Small Cell Lung Cancer Preclinical Model (ResCu)
Authors: L. Hill, M. Gadde, P. Reddy, M. Morri, H. Lan, E. Sanchez, G. Selvaggi, N. Goldner, C. Bulow
Journal: Journal of Thoracic Oncology (2023)
P2.13-04 Pathological Images Machine Learning Predicts Long Term Effects for Immunotherapy in Small-Cell Lung Cancer
Authors: R. Shibaki, D. Fujimoto, T. Nozawa, S. Hara, J. Uchida, E. Miyauchi, R. Hiraoka, H. Daga, T. Masuda, S. Tanaka, S. Ikeda, G. Saito, H. Suzuki, S. Sakata, Y. Sakata, N. Yamamoto, Y. Koh, H. Akamatsu
Journal: Journal of Thoracic Oncology (2023)
P1.17-03 Cost-effectiveness of Low-dose Computerized Tomography Lung Cancer Screening in High-risk Non-smokers and Smokers in Hong Kong
Authors: H. Loong, X. Pan, C.-H. Chiu, S.-C. Yang, M.S.H. Chung, L. de Jong, H. Groen, M. Oudkerk, M.J. Postma, C.K.H. Wong, P.-C. Yang
Journal: Journal of Thoracic Oncology (2023)
P1.27-09 Efficacy and Safety of Aumolertinib as Adjuvant Therapy in Resectable Stage I NSCLC with High-grade Patterns and EGFR Mutations (APPOINT)
Authors: B. Han, W. Fang, C. Chen, W. Zhang, B. Zhang, F. Yao, J. Shi, D. Yue, Y. Qi, Z. Zhu, J. Xie
Journal: Journal of Thoracic Oncology (2023)
P2.10-14 First-line (1L) Lorlatinib in Patients with ALK-Positive aNSCLC: Updated Network Meta-Analysis (NMA) and Review of Ten NMAs
Authors: S.-H.I. Ou, H. Kilvert, J. Candlish, C. Jaiyeola, A. Polli, D. Thomaidou, H. Le, B. Lee
Journal: Journal of Thoracic Oncology (2023)
P2.10-15 Correlation Between Clinical and Health-related Quality-of-Life (HRQoL) Benefits in Patients With ALK+ NSCLC in ALTA-1L
Authors: R. García-Campelo, H.M. Lin, M. Pérol, M. Jahanzeb, A. Szumski, Y. Wu, A. Geiger, E. Goodman, R.J. Fram, S. Popat, D.R. Camidge
Journal: Journal of Thoracic Oncology (2023)
P1.24-10 Clinical Implication of Karyopherin a 2, Which Is a Nuclear Export Protein in Lung Adenocarcinoma
Authors: S. Kim, J.H. Lee, H. Lee, J.-S. Yoon, I. Cheon, S. Lee, H.S. Won, S.A. Hong, K. Kang, J.H. Hong, S.H. Chun, Y.-H. Ahn, Y.H. Ko
Journal: Journal of Thoracic Oncology (2023)
EP06.06-09 Clinical Significance of the Presence of MECA-79-Positive Tumor Cells in Pathological Stage IA Invasive Adenocarcinoma of the Lung
Authors: T. Saito, M. Ishida, T. Akama, M. Suzuki, H. Hanaoka, H. Takahashi, N. Maru, T. Utsumi, H. Matsui, Y. Taniguchi, H. Hino, T. Murakawa
Journal: Journal of Thoracic Oncology (2023)
MA18.03 Preliminary Safety and Treatment Data of A Phase 3 Trial: Hypofractionated vs Conventional Fractionated Concurrent Chemoradiation for LS-SCLC
Authors: N. Bi, T. Zhang, X. Hu, L. Zhang, J. Zhang, J. Cao, M. E, H. Ge, X. Zhu, L. Zhao, W. Jiang, D. Qian, W. Shen, Y. Wang, J. Ran, T. Zhang, C. Hu, M. Chen, L. Wang
Journal: Journal of Thoracic Oncology (2023)
MA04.08 Identifying Early and Late Hallmarks of Plasticity in Neuroendocrine Transformation of Lung Cancer at Single-Cell Level
Authors: J.M. Chan, A. Quintanal-Villalonga, A. Sabet, P. Manoj, I. Masilionis, C. Falcon, N. Sohail, J. Chun, T. Nawy, L. Mazutis, T. Sen, R. Chaligne, H. Yu, D. Pe'er, C. Rudin
Journal: Journal of Thoracic Oncology (2023)
P2.22-03 NUT Midline Carcinoma (NC) Deciphering the Standard of Care in an Ultra-rare Cancer
Authors: M.V. Sanchez-Becerra, None B. Fresnau, None C. Rigaud, None C. Massard, None S. Postel-Vinay, None A-C. Toffart, None J. Chapron, None A. Gazzah, None P. Martin-Romano, None M.R. Ghigna, None J. Cartry, None D. Planchard, None E. Baudin, None N. Cozic, None B. Besse
Journal: Journal of Thoracic Oncology (2023)
P1.11-04 Clinical Implication of Multi-Genomic Analysis about Compound and Uncommon EGFR Mutations in the Non-small Cell Lung Cancer
Authors: J. Lee, S. Kim, J.R. Kim, Y.E. Sung, C.K. Jung, G.J. Lee, S.H. Chun, Y.H. Lee, J.H. Kang
Journal: Journal of Thoracic Oncology (2023)
EP07.01-19 Factors Affecting Postoperative Nausea and Vomiting in Surgical Patients with Non-Small Cell Lung Cancer
Authors: S. Imamura, S. Katsumata, D. Yamaguchi, K. Matsushima, K. Takei, M. Asami, T. Masuda, K. Maeda, H. Kojima, H. Konno, M. Isaka, Y. Ohde
Journal: Journal of Thoracic Oncology (2023)
EP07.05-17 Aumolertinib as Neoadjuvant Therapy for EGFR-mutated Non-Small Cell Lung Cancer: A Subcohort Analysis of the PURPOSE Trial
Authors: Y.-Y. Wang, Z.-T. Gu, F.-C. Bao, T. Mao, C.-Y. Ji, W.-T. Fang
Journal: Journal of Thoracic Oncology (2023)
EP05.01-12 A Retrospective Audit of Lung Nodules with Validation of the Brock Tool in a Singaporean Cohort
Authors: M. Ruparel, C. Khoong, N. Lim, E. Lim, Y. Xu, C.K. Phua, W.-Y. Lim, J. Abisheganaden
Journal: Journal of Thoracic Oncology (2023)
MA04.10 Molecular Characteristics of Non-Small Cell Lung Cancer with MET Fusions
Authors: J. Zaemes, A. Tolulope, A. Elliott, A. Rafeh Naqash, M. Nagasaka, S.Y. Kim, R. Chakra Turaga, M. Oberley, J. Nieva, H. Borghaei, B. Halmos, G.W. Sledge, S.V. Liu, P.C. Ma, C. Kim
Journal: Journal of Thoracic Oncology (2023)
P1.21-07 Quantitative Assessment of OX40L and Its Association with Sensitivity to First-Line Pembrolizumab in Non-small-Cell Lung Cancer
Authors: J. Baena, A. Calles, C. Aguado, M. Antoñanzas, Y. Lage, M. Sereno, X. Mielgo, A. Lopez, R. Cervera, L. Cabezón-Gutierrez, J. Rubio, M.V. Sanchez-Becerra, M. Molero-Abraham, M. Peressini, G. Ruiz de Garibay, C. Fernández-Luna, V. Adradas, M. Herrera, H. Cabo, R. Alvarez, P. Garrido, J.L. Gonzalez-Larriba, F. López-Ríos, E. Conde, L. Paz-Ares, J. Zugazagoitia
Journal: Journal of Thoracic Oncology (2023)
EP07.02-04 The Prediction of Pathological Pleural Invasion of Lung Cancer by Artificial Intelligence Image Analysis
Authors: W. Nagase, Y. Kudo, K. Harada, J. Matsubayashi, P. Jinho, S. Orihara, S. Maehara, M. Hagiwara, M. Kakihana, T. Nagao, T. Ohira, M. Taguri, N. Ikeda
Journal: Journal of Thoracic Oncology (2023)
P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer Patients Who Benefit from Neoadjuvant Chemo-Immunotherapy
Authors: L. Robado de Lope, E. Nadal, V. Calvo, J.L. González-Larriba, A. Insa, A. Martinez-Marti, B. Massutí, C. González, R. Serna Blasco, J. Bosch-Barrera, M.R. Garcia-Campelo, S. Ponce, N. Reguart, R. Bernabé, M. Cobo, J. De Castro, M. Dómine, C. Camps, I. Barneto, G. López-Vivanco, M. Majem, D. Rodríguez-Abreu, R. Palmero, A. Cruz-Bermudez, A. Romero, M. Provencio
Journal: Journal of Thoracic Oncology (2023)
P1.21-02 Genetic Susceptibility to Immune Checkpoints Blockade Resistance
Authors: P. Marin, J.L. Onieva, J. Oliver, M. Garrido, A. Garcia, B. Martinez, J.B. Dubbelman, A. Mesas, I. Ramos, M. Cobo, A. Cantero, V. Gutierrez, E. Perez-Ruiz, J. Zafra, A. Rueda-Dominguez, I. Barragan, J.C. Benítez
Journal: Journal of Thoracic Oncology (2023)

MPR and long-term outcomes were analyzed with Kaplan-Meier methods and Cox proportional hazard analysis.Results: MPR (10% or less viable tumor) was observed in 13 (19.7%)out of 66 patients, based on the average viable tumor percentage rated by the three observers.Fleiss' kappa coefficient for agreement of MPR and ICC for absolute agreement of viable tumor percentage were 0.877 and 0.964, respectively.Kaplan Meier estimates and log-rank tests showed that patients with MPR had improved overall survival (OS) (p¼0.024),progression-free survival (PFS) (p¼0.021), and lung cancer-specific cumulative incidence of death (p¼0.041).MPR was associated with better OS (p¼0.038) and PFS (p¼0.023) on multivariable analysis.Conclusions: High interobserver agreement was noted for MPR evaluation according to IASLC recommendations.MPR was associated with better clinical outcomes in NSCLC patients who underwent neoadjuvant therapy and surgery.
EP12.01-19 Successful Aumolertinib Treatment of Activated EGFR Mutation NSCLC Patients with Interstitial Pneumonia Induced by Osimertinib
Authors: E. Chen, J. Lou, X. Hu, S. Wen, X. Zhu, Z. Jiang, Q. Li, L. Le, Y. Sheng, S. Wu, J. Zou, Y. Lu, J. Chen, H. Xu, H. Zhang
Journal: Journal of Thoracic Oncology (2023)
P2.06-11 Camrelizumab Plus Apatinib as First-Line Treatment for Advanced Squamous Non-small-Cell Lung Cancer: Updated Survival Results of a Phase 2 Trial
Authors: B. Qin, J. Zhai, D. Lu, X. Ge, Y. Mao, S. Sheng, Y. Hu, J. Wang
Journal: Journal of Thoracic Oncology (2023)
MA21.04 Novel Classification with Number or Zones of Involved Lymph Nodal Stations in Patients with Resected Non-Small Cell Lung Cancer
Authors: A. Kamigaichi, T. Mimae, N. Tsubokawa, Y. Miyata, H. Adachi, Y. Shimada, H. Ito, N. Ikeda, M. Okada
Journal: Journal of Thoracic Oncology (2023)
MA04.09 The MET Inhibitor Tepotinib Potentially Inhibits KRAS G12C and SHOC2 in KRAS G12C Non-Small Cell Lung Cancer (NSCLC)
Authors: R. Rosell, A. Jain, J. Codony-Servat, C. Shivamallu, S. Prasad Kollur, A. Prasad, E. Jantus-Lewintre, M. Ito, A.F. Cardona, O. Arrieta, P. Cao, X. Cai, B. Xing, C. Pedraz-Valdunciel, Z. Dantes, I. Sullivan, A. Aguilar, M.A. Molina-Vila, M. González-Cao
Journal: Journal of Thoracic Oncology (2023)
P1.21-19 Potential Utilization of Serum Glycoproteomics as a Biomarker to Predict Survival Outcomes and irAEs in Advanced NSCLC Treated with ICI
Authors: L. Kim, M. Nam, H.S. Kim, W.J. Yang, Y. Lee, C. Pickering, D. Serie, Y.K. Chae
Journal: Journal of Thoracic Oncology (2023)
P1.27-06 Construction of Postoperative Prediction Model Based on the New IASLC Grading System for Early Stage Lung Adenocarcinoma
Authors: H. Jiang, J. Qian, J. Huang, J. Liang, W. Meng, D. Wei, Y. DIng, J. Shen, X. Chen, S. Ma
Journal: Journal of Thoracic Oncology (2023)
P1.28-03 Adjuvant CCRT Does Not Improve Survival Outcomes in Patients with ECE Positive Pathologic Stage III-N2 NSCLC After Upfront Surgery
Authors: J. Son, J. Lee, J. Yun, Y.J. Jeon, S.-Y. Park, J.H. Cho, Y.S. Choi, J. Kim, Y.M. Shim, H.K. Kim
Journal: Journal of Thoracic Oncology (2023)
P1.01-01 Frequency of Germline Mutations in Patients with Non-small Cell Lung Cancer (NSCLC) Harboring Actionable DRIVER Alterations (G-DRIVER)
Authors: M. Jové, M. Gausachs, J. Bosch-Barrera, E. Carcereny, A. Teule, M. Mosteiro, M. Pineda, E. Tornero, R. Palmero, N. Vilarino, J.C. Ruffinelli, C. Mesia, J. Saldaña, A. Cuellar, J. Brenes, A. Hernandez, C. Fina, J. Brunet, M. Domenech, T. Moran, E. Sais, C. Lazaro, E. Nadal
Journal: Journal of Thoracic Oncology (2023)
EP07.01-04 Factors Affecting Survival in YPT1N01M0 Non Small Cell Lung Cancer Patients
Authors: G. Özçibik Isik, I. Sarbay, K. Kaynak, F. Dinçbaş, B. Kiliç, E. Erşen, V. Kara, A. Turna
Journal: Journal of Thoracic Oncology (2023)
EP07.04-05 Spread through Air Spaces in Non-small Cell Lung Cancer. Clinical and Pathological Associations
Authors: V. Calvo de Juan, Y. Garitaonaindía Díaz, M. Martinez Cutillas, C. Traseira, I. Redondo Canovas del Castillo, A. Collazo Lorduy, J. Martin, J.L. Campo Cañaveral, M. Blanco Clemente, A.V. Ospina, C. Salas, S. Crowley, A. Roman, M. Gil Barturen, C. Parejo, M. Provencio
Journal: Journal of Thoracic Oncology (2023)
P1.15-01 Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled with Primary Prevention: Results of the Baseline Round
Authors: G. Veronesi, E. Bottoni, P. Novellis, E. Dieci, M. Profili, E. Lanza, G. Favaro, S. De Santis, D. Pistillo, E. Fina, F. Bianchi, A. Antonicelli, P. Muriana
Journal: Journal of Thoracic Oncology (2023)
EP07.01-25 Implementation and Safety of a Same-day Discharge Program for Minimally-invasive Pulmonary Resection
Authors: P.J. Villeneuve, J. Strain, U. Bhattacharyya, T. Lachapelle, K. Sauve, T. McVey, C. Lesage, S. Gilbert, D. Maziak, A. Seely, S. Sundaresan, C. Thompson
Journal: Journal of Thoracic Oncology (2023)
EP07.04-07 Early-Stage Low Malignant Potential Adenocarcinomas: A Histological Category With A Significantly Better Prognosis
Authors: F. Lococo, M. Chiappetta, A. Cancellieri, J. Evangelista, C. Sassorossi, M.T. Congedo, None q. zhang, P. Straccia, S. Margaritora
Journal: Journal of Thoracic Oncology (2023)
P2.21-04 The Significance of BAP1 and MTAP/CDKN2A Expression in Well-Differentiated Papillary Mesothelial TUmour: A Series of 21 Cases
Authors: S. Prabhakaran, A. Hassan, E. Pulford, D. Godbolt, F. Ziad, A. Pandita, A. Wessels, M. Hussey, S. Klebe
Journal: Journal of Thoracic Oncology (2023)
P2.31-05 Determining Lines of Therapy in Patients with Metastatic Non-Small Cell Lung Cancer Using Real-World Data
Authors: C.B. Grady, L. Sun, J.E. Reuss, A. Cass, G. Liu, D. Patel, S. Liu, G.B. Montenegro, T. Patil, J. Nieva, A. Herrmann, K. Marrone, V. Lam, W. Schwartzman, L. Villaruz, K.L. Miller, D.R. Camidge, C. Aggarwal, W.-T. Hwang, M.E. Marmarelis
Journal: Journal of Thoracic Oncology (2023)
P1.21-03 Upregulation of HLA-I/II and Pro-inflammatory Cells in PBMCs Indicated Efficacy of Neoadjuvant Chemo-immunotherapy in Locally Advanced NSCLC
Authors: L. Hou, T. Hu, J. Wang, T. Sun, C. Zhu, C. Wu, H.K. Xie
Journal: Journal of Thoracic Oncology (2023)
EP10.01-08 Relationship Between Age and Chemotherapy Regimen for Elderly Patients with Advanced Lung Cancer
Authors: R. Shiiba, Y. Kogure, H. Murao, Y. Takigawa, A. Torii, A. Yamada, Y. Shinohara, H. Niwa, M. Sano, C. Kitagawa, M. Oki
Journal: Journal of Thoracic Oncology (2023)
MA04.03 Osimertinib-induced Epigenetic and Transcriptional Reprogramming Drives a BRD4-POUF-PDGFRB-YAP-EMT Axis of Resistance in NSCLC
Authors: A.-V. Hartley, C. Weston, M. Al-Dulaimi, S. Baldacci, W. Feng, M. Booker, M. Tolstorokuv, P. Janne
Journal: Journal of Thoracic Oncology (2023)
P2.31-09 Missed Opportunities for Lung Cancer Personalized Medicine in a Brazilian Public Healthcare Service
Authors: L. Princess Schneider, P. Aguiar, M.A. Fonseca Magalhães Filho, J.H. Maselli Schoueri, C. Vaz de Melo Sette, A. del Giglio
Journal: Journal of Thoracic Oncology (2023)
P2.23-08 Determination of the Best Cut-off Point To Establish the Performance of a Mexican Cohort with Non-small Cell Lung Cancer in the 6-Minute Walk Test
Authors: J.R. Alcantar Correa, C.L. Ble Magana, Z. Hernandez Gracian, C.B. Palomares Palomares, A.P. Gomez Garcia, W. Munoz Montano, B.M. Martinez Hernandez, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
P2.06-08 Phase I/II Study of Rucaparib and Pembrolizumab Maintenance in Stage IV NSCLC after Carboplatin, Pemetrexed, Pembrolizumab
Authors: A. Qin, D. Morgensztern, S. Waqar, D. Owen, S. Gadgeel, B. Schneider, G. Kalemkerian, J. Rice, N. Ramnath
Journal: Journal of Thoracic Oncology (2023)
P2.25-02 Resiliency among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): A Novel Pilot Supportive Care Intervention Study
Authors: S. Farid, M.M. Grogan, A. Compton, K. Hock, B. Knauss, N. Arrato, S.B. Lo, S.A. Janse, J. Benedict, S. Wells Di Gregorio, H. Mcginty, B.L. Andersen, E.D. Paskett, C.J. Presley
Journal: Journal of Thoracic Oncology (2023)
OA22.05 TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study
Authors: T. Leal, R. Kotecha, R. Ramlau, L. Zhang, J. Milanowski, M. Cobo, J. Roubec, L. Petruzelka, L. Havel, S. Kalmadi, J. Ward, Z. Andric, T. Berghmans, D.E. Gerber, G. Kloecker, R. Panikkar, J. Aerts, A. Delmonte, M. Pless, R. Greil, C. Rolfo, W. Akerley, M. Eaton, M. Iqbal, C. Langer
Journal: Journal of Thoracic Oncology (2023)
P1.22-09 Molecular Profiling Reveals Distinct Clinical and Genomic Features as Potential Therapeutic Targets in Pulmonary Spindle Cell Carcinoma
Authors: Y. Sun, S. Qin, S. Wang, J. Pang, Q. Ou, Y. Shao, W. Liang, H. Zhong
Journal: Journal of Thoracic Oncology (2023)